Treatment of Primary Hyperparathyroidism with Denosumab and Cinacalcet
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Cinacalcet (Primary) ; Denosumab (Primary)
- Indications Osteoporosis; Primary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms Denocina
- 27 Jun 2017 Planned primary completion date changed from 1 Feb 2019 to 1 Mar 2019.
- 27 Jun 2017 Status changed from not yet recruiting to recruiting.
- 08 Jul 2016 New trial record